Amivantamab and Recombinant Human Hyaluronidase Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of amivantamab and recombinant human hyaluronidase that may be used in the treatment of non-small cell lung cancer (NSCLC).

**Synonyms:** - Amivantamab and Hyaluronidase Regimen - Amivantamab and Hyaluronidase-lpuj Regimen - Amivantamab/Hyaluronidase Regimen - Amivantamab/Hyaluronidase-lpuj Regimen - Rybrevant Faspro Regimen